Latest Breaking News On - பர்கண்டி பள்ளி - Page 2 : comparemela.com

Brings Deep Expertise in Corporate Strategy, Business Development and Commercialization PHILADELPHIA, May 06, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD) today announced the appointment of Sébastien Martel as Senior Vice President of Strategy and Business Development. Mr. Martel will lead the Company’s corporate strategy and business and corporate development endeavors. He will be a member of the Amicus senior leadership team. Mr. Martel brings 25 years of diversified pharmaceutical and biotechnology expertise to Amicus, with extensive experience in rare disease, most recently as Senior Vice President, Global Head of Rare Diseases at Sanofi. Mr. Martel has played a key role in managing the launch and growth of several products across therapeutic areas and has had significant involvement in strategic merger and acquisition transactions and business development deals. He brings a proven track record in corporate and business development, global marketing, product

United statesAndrew faughnanDiana mooreSanofi genzymeJohnf crowleyNovo nordiskAmicus therapeuticsBurgundy school of businessUniversity of angersBusiness schoolHead of global corporate communicationsAmicus therapeutics incMerck kgaMerck kgaaBusiness developmentMost recently served